Superior Serum Concentrations with Posaconazole Delayed-Release Tablets Compared to Suspension Formulation in Hematological MalignanciesAaron Cumpston, Abraham S. Kanate, Ryan Caddell et al.|Antimicrobial Agents and Chemotherapy|2015Cited by 68
Hematopoietic progenitor cell mobilization with “just-in-time” plerixafor approach is a cost-effective alternative to routine plerixafor useLauren Veltri, Abraham S. Kanate, Aaron Cumpston et al.|Cytotherapy|2015Cited by 33
Treatment of severe mucositis pain with oral ketamine mouthwashAlexandra Shillingburg, Aaron Cumpston, Abraham S. Kanate et al.|Supportive Care in Cancer|2017Cited by 31
Evaluation of Serum Posaconazole Concentrations in Patients with Hematological Malignancies Receiving Posaconazole Suspension Compared to the Delayed-Release Tablet FormulationMorgan Belling, Aaron Cumpston, Abraham S. Kanate et al.|Leukemia Research and Treatment|2017Cited by 27
Impact of intravenous magnesium infusion rate during ambulatory replacements on serum magnesium concentrations after allogeneic stem cell transplantMatthew Snyder, Aaron Cumpston, Alexandra Shillingburg et al.|Supportive Care in Cancer|2016Cited by 8